1. Academic Validation
  2. Discovery of 1-(2,4-dichlorophenyl)-4-ethyl-5-(5-(2-(4-(trifluoromethyl)phenyl)ethynyl)thiophen-2-yl)-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide as a potential peripheral cannabinoid-1 receptor inverse agonist

Discovery of 1-(2,4-dichlorophenyl)-4-ethyl-5-(5-(2-(4-(trifluoromethyl)phenyl)ethynyl)thiophen-2-yl)-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide as a potential peripheral cannabinoid-1 receptor inverse agonist

  • ChemMedChem. 2010 Sep 3;5(9):1439-43. doi: 10.1002/cmdc.201000246.
Ming-Shiu Hung 1 Chun-Ping Chang Ting-Chieh Li Teng-Kuang Yeh Jen-Shin Song Yinchiu Lin Chien-Huang Wu Po-Chu Kuo Prashanth K Amancha Ying-Chieh Wong Wen-Chi Hsiao Yu-Sheng Chao Kak-Shan Shia
Affiliations

Affiliation

  • 1 Division of Biotechnology and Pharmaceutical Research, National Health Research Institutes, 35, Keyan Road, Zhunan Town, Miaoli County 35053, Taiwan, ROC.
Figures
Products